Novartis will price its new Mayzent multiple sclerosis drug at $88,000 dollars per year, the Swiss company's head of pharmaceuticals, Paul Hudson, said.
from Reuters: Health News https://ift.tt/2TZ36ZP
Copyright (c) 2019 todaystimeline.blogspot.com All Right Reseved
0 Comments